Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
75.28
+0.63 (0.84%)
May 20, 2024, 1:11 PM EDT - Market open
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of $110.71 billion as of May 20, 2024. Its market cap has increased by 44.24% in one year.
Market Cap
110.71B
Enterprise Value
118.97B
1-Year Change
44.24%
Ranking
Category
Stock Price
$75.28
Market Cap Chart
Since December 1, 1998, Boston Scientific's market cap has increased from $10.63B to $110.71B, an increase of 941.28%. That is a compound annual growth rate of 9.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 109.75B | 0.13% |
May 16, 2024 | 109.60B | 0.13% |
May 15, 2024 | 109.45B | 1.31% |
May 14, 2024 | 108.04B | 0.93% |
May 13, 2024 | 107.04B | -1.19% |
May 10, 2024 | 108.34B | -0.55% |
May 9, 2024 | 108.94B | 1.90% |
May 8, 2024 | 106.91B | -0.97% |
May 7, 2024 | 107.96B | 1.21% |
May 6, 2024 | 106.66B | -0.41% |
May 3, 2024 | 107.10B | 1.14% |
May 2, 2024 | 105.90B | -0.25% |
May 1, 2024 | 106.16B | 0.68% |
Apr 30, 2024 | 105.44B | -0.87% |
Apr 29, 2024 | 106.36B | -0.92% |
Apr 26, 2024 | 107.35B | -0.12% |
Apr 25, 2024 | 107.48B | 0.48% |
Apr 24, 2024 | 106.97B | 5.68% |
Apr 23, 2024 | 101.21B | 1.43% |
Apr 22, 2024 | 99.79B | 1.02% |
Apr 19, 2024 | 98.78B | -0.13% |
Apr 18, 2024 | 98.91B | -0.79% |
Apr 17, 2024 | 99.70B | -0.23% |
Apr 16, 2024 | 99.94B | 1.01% |
Apr 15, 2024 | 98.94B | -0.93% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Stryker | 127.56B |
Elevance Health | 127.20B |
Vertex Pharmaceuticals | 115.03B |
Medtronic | 114.17B |
Sanofi | 112.48B |
Regeneron Pharmaceuticals | 106.25B |
Cigna | 96.20B |
GSK | 91.81B |